Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT)

40 filings reported holding BOLT - Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share as of Q2 2024.
Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 22,625,730 shares of 38,512,859 outstanding shares and own 59% of the company stock.
Largest 10 shareholders include TANG CAPITAL MANAGEMENT LLC (3,812,773 shares), Vivo Capital, LLC (3,521,291 shares), Sofinnova Investments, Inc. (2,754,437 shares), CITADEL ADVISORS LLC (2,367,511 shares), Pivotal bioVenture Partners Investment Advisor LLC (1,891,467 shares), Newtyn Management, LLC (1,363,234 shares), Nan Fung Group Holdings Ltd (1,166,952 shares), VANGUARD GROUP INC (1,067,405 shares), Samsara BioCapital, LLC (1,049,153 shares), and Board of Trustees of The Leland Stanford Junior University (719,546 shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.